• OSMI-1: Precision O-GlcNAc Transferase Inhibition for Preecl

  2026-06-03

  OSMI-1 enables researchers to dissect O-GlcNAcylation dynamics in placental biology and ferroptosis with unmatched specificity. Its robust cell permeability and validated potency support advanced experimental workflows and troubleshooting in syncytialization and iron-regulation models.

• Trelagliptin Succinate: Experimental Workflows in Diabetes R

  2026-06-02

  Trelagliptin succinate (SYR-472 succinate) stands out as a long-acting, selective DPP-4 inhibitor uniquely positioned for translational diabetes and metabolic disease research. This article translates recent mechanistic advances and protocol guidance into actionable workflows—empowering researchers to optimize assays, troubleshoot common challenges, and leverage novel neuroprotective and anti-inflammatory effects.

• Gemcitabine HCl Workflows: Imaging-Driven Pancreatic Cancer

  2026-06-02

  Gemcitabine HCl unlocks precise, high-throughput tumor monitoring in pancreatic cancer models by synergizing with multianimal MRI protocols. This article details actionable workflows, troubleshooting strategies, and the unique strengths of APExBIO's reagent for translational oncology.

• Entinostat (MS-275) Workflows: Precision in Cancer Cell Assa

  2026-06-01

  Entinostat (MS-275) empowers researchers to pinpoint HDAC1/3-driven epigenetic changes for cancer cell proliferation inhibition and apoptosis induction. This guide details best-practice workflows, actionable troubleshooting, and experimental enhancements that set Entinostat apart for reproducible oncology research.

• Luminescent ATP Cell Viability Assay Kit I: Precision for Mo

  2026-06-01

  The Luminescent ATP Cell Viability Assay Kit I delivers unmatched sensitivity and workflow simplicity for cell viability measurement, making it ideal for cytotoxicity and cell metabolism assays. Its rapid, luciferase-based luminescence detection enables high-throughput, quantitative insights—outperforming legacy colorimetric methods and accelerating translational research.

• Myriocin: Precision Serine Palmitoyltransferase Inhibitor Wo

  2026-05-31

  Myriocin's nanomolar potency as a serine palmitoyltransferase inhibitor enables precise dissection of sphingolipid metabolism and cell cycle regulation in cancer and immunology research. This guide translates recent peer-reviewed workflows and troubleshooting strategies into actionable protocols, highlighting comparative advantages and practical solutions for reproducibility.

• Activity-Driven Synaptic Protein Trafficking via Proximity L

  2026-05-30

  The referenced study introduces a rapid, synaptic cleft-targeted biotinylation method to monitor endogenous protein trafficking during neuronal activity. This approach overcomes longstanding barriers in quantifying transient presynaptic surface protein exposure, offering new insights into synaptic vesicle cycling and neurotransmission mechanisms.

• Necrosulfonamide (NSA): Redefining MLKL Inhibition in Necrop

  2026-05-29

  Necrosulfonamide (NSA) is a powerful MLKL inhibitor unlocking precision in necroptosis and cell death pathway research. Discover how NSA advances mechanistic studies, informed by cutting-edge cardiovascular findings, and optimizes experimental design.

• p-Cresyl Sulfate Drives Aortic Valve Calcification via Kloth

  2026-05-29

  This study demonstrates that p-cresyl sulfate, a uremic toxin accumulating in CKD, directly enhances calcification of aortic valvular interstitial cells by disrupting klotho and sirtuin-1 (SIRT1) signaling. These mechanistic insights suggest klotho and SIRT1 as promising therapeutic targets in CKD-associated calcific aortic valve disease.

• Bedaquiline as a Metabolic Disruptor: Beyond Classical Antib

  2026-05-28

  Explore how Bedaquiline, a diarylquinoline antibiotic, revolutionizes both multi-drug resistant tuberculosis treatment and cancer metabolism research by targeting cellular energy systems. This article offers an in-depth, assay-focused guide distinct from previous reviews.

• Fluo-4 AM: Precision Fluorescent Calcium Indicator for Cell

  2026-05-28

  Fluo-4 AM is a high-sensitivity fluorescent calcium indicator enabling real-time intracellular calcium concentration measurement. Its robust fluorescence, rapid cell permeability, and compatibility with functional assays make it indispensable for advanced cell signaling research and pharmacological assessment of calcium-dependent processes.

• Genistein: Mechanisms and Benchmarks in Tyrosine Kinase Inhi

  2026-05-27

  Genistein (5,7-dihydroxy-3-(4-hydroxyphenyl)chromen-4-one) is a selective inhibitor of protein tyrosine kinases, widely used to dissect oncogenic signaling and cytoskeleton-dependent autophagy. Its validated efficacy in cancer chemoprevention and cell proliferation inhibition is supported by robust, quantitative assays. This article details Genistein’s mechanism, protocol parameters, and application boundaries for research in cancer biology.

• EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1

  2026-05-27

  EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) is a water-soluble carbodiimide reagent used to activate carboxyl groups for amide bond formation in aqueous peptide synthesis, bioconjugation, and nucleotide coupling. It is intended for controlled in vitro workflows and should not be used in in vivo or clinical settings due to a lack of supporting data.

• ATS-9R and the Future of Adipocyte-Selective Gene Therapy

  2026-05-26

  Explore how ATS-9R (Adipocyte-targeting sequence-9-arginine) is redefining targeted gene delivery and gene silencing in adipocytes with an unmatched precision and safety profile. This article provides a comprehensive technical analysis, actionable protocols, and a critical comparison with alternative approaches.

• Trichostatin A (TSA): Advanced Epigenetic Modulation in Canc

  2026-05-26

  Explore how Trichostatin A (TSA) empowers next-generation cancer research through precise epigenetic modulation. This in-depth analysis reveals new mechanistic insights and innovative applications not covered in standard TSA protocols.

452 records 16/31 page Previous Next First page 上5页 1617181920 下5页 Last page